Recent Quotes (30 days)

You have no recent quotes
chg | %

Pyng Medical Corp.  

(Public, CVE:PYT)   Watch this stock  
Find more results for PYT
0.0400
-0.0200 (-33.33%)
Apr 24 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.04 - 0.04
52 week 0.02 - 0.07
Open 0.04
Vol / Avg. 42,000.00/9,490.00
Mkt cap 943,500.00
P/E     -
Div/yield     -
EPS -0.03
Shares 23.59M
Beta 0.22
Inst. own     -
Feb 24, 2015
Q1 2015 Pyng Medical Corp Earnings Release
  

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -7.20% -15.09%
Operating margin 0.43% -8.54%
EBITD margin - 3.77%
Return on average assets -7.16% -11.93%
Return on average equity -12.40% -21.76%
CDP Score - -

Address

210 - 13480 Crestwood Place
RICHMOND, BC V6V 2J9
Canada
+1-604-3037964 (Phone)
+1-604-3037987 (Fax)

Website links

Description

Pyng Medical Corp. (Pyng) is a Canada-based medical device company that develops, manufactures and markets a suite of trauma and resuscitation products. The Company�s product portfolio includes Sternal Intraosseous (sternal IO), pelvic stabilization and tourniquet devices specifically designed for both the military and civilian markets. Pyng develops medical devices for use by hospital staff, emergency medical services and military forces. Its products include FASTResponder, Fast1 Sternal IO, Fastcombat Sternal IO, T-Podresponder Pelvic Stabilization Device, T-Podcombat Pelvic Stabilization Device, Matresponder Tourniquet and Matcombat Tourniquet. The Company operates in Canada and the United States.

Officers and directors

Ronald Blanck Independent Chairman of the Board
Mark F. Hodge President, Chief Executive Officer
George G. Dorin Chief Financial Officer, Corporate Secretary
Age: 62
Robert Di Silvio Director
Age: 61
Alan L. Moloff Director
Herbert A. Toms III Director
L. J. Evans Jr. Independent Director